{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:01:02Z","timestamp":1780365662409,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SEOR\u2013FEOR"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04321-9","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:01:51Z","timestamp":1780362111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton therapy in Spain: SEOR-SPROMP multidisciplinary recommendations developed through a RAND\/UCLA consensus process"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-0924","authenticated-orcid":false,"given":"Antonio Jos\u00e9","family":"Conde-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe \u00c1ngel","family":"Calvo Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Diezhandino Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Celada \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigfredo Elias","family":"Romero Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Eraso Uri\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Esteban Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Fortes de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"L\u00f3pez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Ramos Albiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ruiz-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"4321_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpt.2025.101212","volume":"18","author":"A L\u00fchr","year":"2025","unstructured":"L\u00fchr A, Mohan R, Mahajan A, Shih HA, Paganetti H. Relative Biological Effectiveness-Clinical Practice at US Proton Therapy Centers. Int J Part Ther. 2025;18:101212.","journal-title":"Int J Part Ther"},{"key":"4321_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/mp.70187","volume":"52","author":"S Wei","year":"2025","unstructured":"Wei S, Qi H, Xu L, Selvaraj B, Zhao X, Zheng A, et al. Proton pencil beam scanning ultra-high dose rate 3D lattice radiotherapy: A proof-of-concept FLASH SFRT study. Med Phys. 2025;52:e70187.","journal-title":"Med Phys"},{"key":"4321_CR3","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ae19c7","author":"N Olovsson","year":"2025","unstructured":"Olovsson N, Wikstr\u00f6m K, Flejmer A, Dasu A. Robust treatment planning and displacement vector field editing for the probabilistic evaluation of proton radiotherapy of small lung tumors. Phys Med Biol. 2025. https:\/\/doi.org\/10.1088\/1361-6560\/ae19c7.","journal-title":"Phys Med Biol"},{"key":"4321_CR4","doi-asserted-by":"crossref","unstructured":"Webster M, Podgorsak A, Li F, Zhou Y, Jung H, Yoon J, et al. New Approaches in Radiotherapy. Cancers (Basel) [Internet]. 2025;17. Available from: https:\/\/www.mdpi.com\/2072-6694\/17\/12\/1980","DOI":"10.3390\/cancers17121980"},{"key":"4321_CR5","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.37765\/ajmc.2020.42398","volume":"26","author":"A Parikh-Patel","year":"2020","unstructured":"Parikh-Patel A, Morris CR, Maguire FB, Daly ME, Kizer KW. A population-based assessment of proton beam therapy utilization in California. Am J Manag Care. 2020;26:e28-35.","journal-title":"Am J Manag Care"},{"key":"4321_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9025","volume":"5","author":"LM Nogueira","year":"2022","unstructured":"Nogueira LM, Jemal A, Yabroff KR, Efstathiou JA. Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004\u20132018. JAMA Netw open. 2022;5:e229025.","journal-title":"JAMA Netw open"},{"key":"4321_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235545","author":"MG Vincini","year":"2023","unstructured":"Vincini MG, Zaffaroni M, Schwarz M, Marvaso G, Mastroleo F, Volpe S, et al. More than five decades of proton therapy: a bibliometric overview of the scientific literature. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15235545.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4321_CR8","doi-asserted-by":"publisher","first-page":"32155","DOI":"10.1002\/pbc.32155","volume":"73","author":"N Esiashvili","year":"2025","unstructured":"Esiashvili N, Indelicato DJ, Mahajan A, Parkes J, Paulino AC, Beljoudi G, et al. Selection of the most appropriate radiation treatment modality for children\u2019s cancers: a paediatric radiation oncology society (pros) position paper on the ethical utilization of proton therapy. Pediatr Blood Cancer. 2025;73(2):32155.","journal-title":"Pediatr Blood Cancer."},{"key":"4321_CR9","unstructured":"American Society for Radiation Oncology (ASTRO). Model Policies. Proton Beam Therapy. 2022;1\u20139. Available from: https:\/\/www.astro.org\/astro\/media\/astro\/daily practice\/pdfs\/astropbtmodelpolicy.pdf"},{"key":"4321_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/1878-0261.12677","volume":"14","author":"C Grau","year":"2020","unstructured":"Grau C, Durante M, Georg D, Langendijk JA, Weber DC. Particle therapy in Europe. Mol Oncol. 2020;14:1492\u20139. https:\/\/doi.org\/10.1002\/1878-0261.12677.","journal-title":"Mol Oncol"},{"key":"4321_CR11","unstructured":"Garc\u00eda S, Cabrera P, Herruzo I, Matute R, Aristu J, Calvo FA, et al. Recomendaciones de la SEOR para la Protonterapia en Espa\u00f1a [Internet]. Ficha 13. 2015. p. 7. Available from: https:\/\/seor.es\/wp-content\/uploads\/2020\/02\/Recomendaciones_Protonterapia_Completo_DIGITAL.pdf"},{"key":"4321_CR12","unstructured":"Azcona Armend\u00e1riz D, Calvo Manuel F, Contreras Mart\u00ednez J, G\u00f3mez Caama\u00f1o A, Mazal DA, P\u00e9rez Romasanta LA, et al. Recomendaciones de la Comisi\u00f3n mixta de SEOR y SEFM en relaci\u00f3n con la instalaci\u00f3n de Unidades de Protonterapia en Espa\u00f1a [Internet]. 2022 [cited 2025 Dec 2]. p. 1\u201315. Available from: https:\/\/seor.es\/wp-content\/uploads\/2022\/07\/Documento-SEOR-SEFM-Protonterapia.pdf"},{"key":"4321_CR13","unstructured":"Solans M, Almazan C, Espin\u00e0s JA. La protonterapia en el tratamiento del c\u00e1ncer [Internet]. Ficha 11. 2014 [cited 2025 Dec 2]. p. 17. Available from: https:\/\/aquas.gencat.cat\/web\/.content\/minisite\/aquas\/publicacions\/2024\/protonterapia-tratamiento-cancer-redets-aquas2024.pdf"},{"key":"4321_CR14","unstructured":"Ministerio de Sanidad. Resoluci\u00f3n de 4 de abril de 2025 de la Direcci\u00f3n General de Cartera Com\u00fan de Servicios del Sistema Nacional de Salud y Farmacia, por la que se hacen p\u00fablicos los acuerdos de la Comisi\u00f3n de Prestaciones, Aseguramiento y Financiaci\u00f3n de 27 de febrero de 202 [Internet]. Bolet\u00edn Of. del Estado. 2025. Available from: https:\/\/www.sanidad.gob.es\/profesionales\/prestacionesSanitarias\/CarteraDeServicios\/ContenidoCS\/docs\/Resol_protonterapia_2025.pdf"},{"key":"4321_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jmrs.885","volume":"72","author":"L Wood","year":"2025","unstructured":"Wood L, Giles E, Cunningham L, Le H, Zientara N, Short M. Proton therapy patient selection methods and the impact of covid-19: a cross-sectional international survey. J Med Radiat Sci. 2025;72:333\u201340.","journal-title":"J Med Radiat Sci"},{"key":"4321_CR16","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.15537\/smj.2025.46.11.20250572","volume":"46","author":"SA Aljabab","year":"2025","unstructured":"Aljabab SA, Aldehaim MA, AlHussain HA, Bahadur YA, Alomary IS, Al Othman MO, et al. Proton beam therapy indications in the Kingdom of Saudi Arabia: A SARO clinical practice guideline. Saudi Med J. 2025;46:1280\u201399.","journal-title":"Saudi Med J"},{"key":"4321_CR17","unstructured":"Fitch K. The Rand\/UCLA appropriateness method user\u2019s manual . Santa Monica: Rand; 2001."},{"key":"4321_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112678","author":"A Mirandola","year":"2022","unstructured":"Mirandola A, Russo S, Bonora M, Vischioni B, Camarda AM, Ingargiola R, et al. A patient selection approach based on NTCP models and DVH parameters for definitive proton therapy in locally advanced sinonasal cancer patients. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14112678.","journal-title":"Cancers (Basel)"},{"key":"4321_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx208","author":"V Verma","year":"2018","unstructured":"Verma V, Simone CB 2nd, Mishra MV. Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review. J Natl Cancer Inst. 2018. https:\/\/doi.org\/10.1093\/jnci\/djx208.","journal-title":"J Natl Cancer Inst"},{"key":"4321_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","volume":"34","author":"LJ Boersma","year":"2022","unstructured":"Boersma LJ, Sattler MGA, Maduro JH, Bijker N, Essers M, van Gestel CMJ, et al. Model-based selection for proton therapy in breast cancer: development of the national indication protocol for proton therapy and first clinical experiences. Clin Oncol (R Coll Radiol). 2022;34:247\u201357.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4321_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2019.01.007","volume":"134","author":"MP Lawell","year":"2019","unstructured":"Lawell MP, Bajaj BVM, Gallotto SL, Hess CB, Patteson BE, Nartowicz JA, et al. Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2019;134:25\u20139.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"4321_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpt.2024.100737","volume":"15","author":"B Vischioni","year":"2025","unstructured":"Vischioni B, Barcellini A, Magro G, Rotondi M, Durante M, Facoetti A, et al. Radioresistant, Rare, Recurrent, and Radioinduced: 4Rs of hadrontherapy for patients selections. Int J Part Ther. 2025;15:100737.","journal-title":"Int J Part Ther"},{"key":"4321_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fonc.2015.00261","volume":"5","author":"BR Eaton","year":"2015","unstructured":"Eaton BR, MacDonald SM, Yock TI, Tarbell NJ. Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol. 2015;5:261.","journal-title":"Front Oncol"},{"key":"4321_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2025.100721","volume":"33","author":"M Weessies","year":"2025","unstructured":"Weessies M, Bellezzo M, Hupkens BJP, Verhaegen F, Vilches-Freixas G. Out-of-field dose assessment for pencil beam scanning proton radiotherapy versus photon radiotherapy for breast cancer in pregnant women. Phys Imaging Radiat Oncol. 2025;33:100721.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"4321_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.adro.2019.07.008","volume":"4","author":"NY Yu","year":"2019","unstructured":"Yu NY, Gamez ME, Hartsell WF, Tsai HK, Laramore GE, Larson GL, et al. A Multi-institutional experience of proton beam therapy for sinonasal tumors. Adv Radiat Oncol. 2019;4:689\u201398.","journal-title":"Adv Radiat Oncol"},{"key":"4321_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/cco.2016.07.05","volume":"5","author":"G Noel","year":"2016","unstructured":"Noel G, Gondi V. Proton therapy for tumors of the base of the skull. Chin Clin Oncol. 2016;5:51.","journal-title":"Chin Clin Oncol"},{"key":"4321_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijrobp.2016.03.053","volume":"96","author":"J Phan","year":"2016","unstructured":"Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, et al. Reirradiation of head and neck cancers with proton therapy: outcomes and analyses. Int J Radiat Oncol Biol Phys. 2016;96:30\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4321_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ijrobp.2016.07.037","volume":"96","author":"MW McDonald","year":"2016","unstructured":"McDonald MW, Zolali-Meybodi O, Lehnert SJ, Estabrook NC, Liu Y, Cohen-Gadol AA, et al. Reirradiation of recurrent and second primary head and neck cancer with proton therapy. Int J Radiat Oncol Biol Phys. 2016;96:808\u201319.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4321_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.41538","volume":"5","author":"I Youssef","year":"2022","unstructured":"Youssef I, Yoon J, Mohamed N, Zakeri K, Press RH, Chen L, et al. Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy. JAMA Netw Open. 2022;5:e2241538.","journal-title":"JAMA Netw Open"},{"key":"4321_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11864-021-00847-y","volume":"22","author":"N Taku","year":"2021","unstructured":"Taku N, Wang L, Garden AS, Rosenthal DI, Gunn GB, Morrison WH, et al. Proton therapy for HPV-associated oropharyngeal cancers of the head and neck: a de-intensification strategy. Curr Treat Options Oncol. 2021;22:54.","journal-title":"Curr Treat Options Oncol"},{"key":"4321_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mp.17916","volume":"52","author":"BA De Jong","year":"2025","unstructured":"De Jong BA, Zhao L, Liu P, Wase V, Marthin O, Sundstr\u00f6m J, et al. Early generation dynamic and static proton arc treatment planning algorithms assessment in oropharyngeal cancer patients. Med Phys. 2025;52:e17916.","journal-title":"Med Phys"},{"key":"4321_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112587","author":"S Nuyts","year":"2022","unstructured":"Nuyts S, Bollen H, Ng SP, Corry J, Eisbruch A, Mendenhall WM, et al. Proton therapy for squamous cell carcinoma of the head and neck: early clinical experience and current challenges. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14112587.","journal-title":"Cancers (Basel)"},{"key":"4321_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijrobp.2015.12.351","volume":"95","author":"AL Holtzman","year":"2016","unstructured":"Holtzman AL, Hoppe BS, Letter HP, Bryant C, Nichols RC, Henderson RH, et al. Proton therapy as salvage treatment for local relapse of prostate cancer following cryosurgery or high-intensity focused ultrasound. Int J Radiat Oncol Biol Phys. 2016;95:465\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4321_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.prro.2023.04.006","volume":"13","author":"M Trotta","year":"2023","unstructured":"Trotta M, Patel KR, Singh S, Verma V, Ryckman J. Safety of radiation therapy in patients with prostate cancer and inflammatory bowel disease: a systematic review. Pract Radiat Oncol. 2023;13:454\u201365.","journal-title":"Pract Radiat Oncol"},{"key":"4321_CR35","doi-asserted-by":"crossref","unstructured":"Lenfant L, Seisen T, Parra J, Vaessen C, Roupr\u00eat M. Tratamiento conservador de los tumores de la v\u00eda excretora superior. EMC - Urol [Internet]. 2022;54:1\u201313. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1761331022460634","DOI":"10.1016\/S1761-3310(22)46063-4"},{"key":"4321_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101456","volume":"9","author":"SS Dastgheyb","year":"2024","unstructured":"Dastgheyb SS, Dreyfuss AD, LaRiviere MJ, Mohiuddin JJ, Baumann BC, Shabason J, et al. A Prospective Phase I\/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas. Adv Radiat Oncol. 2024;9:101456.","journal-title":"Adv Radiat Oncol"},{"key":"4321_CR37","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ijrobp.2003.11.028","volume":"58","author":"DC Weber","year":"2004","unstructured":"Weber DC, Trofimov AV, Delaney TF, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys. 2004;58:1596\u2013606.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4321_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.radonc.2017.06.024","volume":"124","author":"DM Guttmann","year":"2017","unstructured":"Guttmann DM, Frick MA, Carmona R, Deville CJ, Levin WP, Berman AT, et al. A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;124:271\u20136.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"4321_CR39","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/j.ijrobp.2020.07.1576","volume":"108","author":"P Mohindra","year":"2020","unstructured":"Mohindra P, Nichols EM, Kesslering CM, Tsai HK, Vargas CE, Dyer BA, et al. Clinical practice patterns for proton therapy in gynecological cancers: report from a prospective multi-institutional registry. Int J Radiat Oncol Biol Phys. 2020;108:e498\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.07.1576.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4321_CR40","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.19.02503","volume":"38","author":"SH Lin","year":"2020","unstructured":"Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, et al. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38:1569\u201379.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4321_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13014-023-02371-9","volume":"18","author":"N Ma","year":"2023","unstructured":"Ma N, Ming X, Chen J, Wu K-L, Lu J, Jiang G, et al. Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis. Radiat Oncol. 2023;18:195.","journal-title":"Radiat Oncol"},{"key":"4321_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2021.101638","volume":"38","author":"M Fok","year":"2021","unstructured":"Fok M, Toh S, Easow J, Fowler H, Clifford R, Parsons J, et al. Proton beam therapy in rectal cancer: A systematic review and meta-analysis. Surg Oncol. 2021;38:101638.","journal-title":"Surg Oncol"},{"key":"4321_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/jrr\/rrae019","volume":"65","author":"Y Takagawa","year":"2024","unstructured":"Takagawa Y, Suzuki M, Seto I, Azami Y, Machida M, Takayama K, et al. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation. J Radiat Res. 2024;65:379\u201386.","journal-title":"J Radiat Res"},{"key":"4321_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4143\/crt.2013.218","volume":"47","author":"TH Kim","year":"2015","unstructured":"Kim TH, Park J-W, Kim Y-J, Kim BH, Woo SM, Moon SH, et al. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma. Cancer Res Treat. 2015;47:34\u201345.","journal-title":"Cancer Res Treat"},{"key":"4321_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.21037\/jgo.2019.03.02","volume":"11","author":"MS Rutenberg","year":"2020","unstructured":"Rutenberg MS, Nichols RC. Proton beam radiotherapy for pancreas cancer. J Gastrointest Oncol. 2020;11:166\u201375.","journal-title":"J Gastrointest Oncol"},{"key":"4321_CR46","first-page":"63","volume":"9","author":"MT McMillan","year":"2023","unstructured":"McMillan MT, Shepherd AF, Kang M, Lin L, Shaverdian N, Wu AJ, et al. Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors. J radiosurgery SBRT. 2023;9:63\u201374.","journal-title":"J radiosurgery SBRT"},{"key":"4321_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.prro.2017.07.002","volume":"8","author":"JC Ho","year":"2018","unstructured":"Ho JC, Nguyen Q-N, Li H, Allen PK, Zhang X, Liao Z, et al. Reirradiation of thoracic cancers with intensity modulated proton therapy. Pract Radiat Oncol. 2018;8:58\u201365.","journal-title":"Pract Radiat Oncol"},{"key":"4321_CR48","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1016\/j.ijrobp.2020.07.1191","volume":"108","author":"AR Barsky","year":"2020","unstructured":"Barsky AR, Maxwell RJL, Marmarelis ME, Singhal S, Li YR, Alley E, et al. Prospective assessment of proton therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2020;108:e90\u20131. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.07.1191.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4321_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061445","author":"JM Noh","year":"2022","unstructured":"Noh JM, Yoo H, Lee W, Park HY, Shin SH, Pyo H. Prospective study of proton therapy for lung cancer patients with poor lung function or pulmonary fibrosis. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14061445.","journal-title":"Cancers (Basel)"},{"key":"4321_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000328257","volume":"49","author":"L Desjardins","year":"2012","unstructured":"Desjardins L, Lumbroso-Le Rouic L, Levy-Gabriel C, Cassoux N, Dendale R, Mazal A, et al. Treatment of uveal melanoma by accelerated proton beam. Dev Ophthalmol. 2012;49:41\u201357.","journal-title":"Dev Ophthalmol"},{"key":"4321_CR51","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1038\/s41433-025-03934-8","volume":"39","author":"L Lumbroso-Le Rouic","year":"2025","unstructured":"Lumbroso-Le Rouic L, Maynadier X, Goudjil F, Dendale R, Matet A, Dureau S, et al. Long-term follow-up of circumscribed iris melanomas treated by proton beam therapy. Eye. 2025;39:2599\u2013603. https:\/\/doi.org\/10.1038\/s41433-025-03934-8.","journal-title":"Eye"},{"issue":"5","key":"4321_CR52","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ajo.2014.07.013","volume":"158","author":"AI Riechardt","year":"2014","unstructured":"Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, et al. Salvage proton beam therapy in local recurrent uveal melanoma. Am J Ophthalmol. 2014;158(5):948\u201356.","journal-title":"Am J Ophthalmol"},{"key":"4321_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102209","volume":"98","author":"M Mizumoto","year":"2021","unstructured":"Mizumoto M, Fuji H, Miyachi M, Soejima T, Yamamoto T, Aibe N, et al. Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines. Cancer Treat Rev. 2021;98:102209.","journal-title":"Cancer Treat Rev"},{"key":"4321_CR54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s12519-023-00726-6","volume":"19","author":"\u00c1 Lassaletta","year":"2023","unstructured":"Lassaletta \u00c1, Morales JS, Valenzuela PL, Esteso B, Kahalley LS, Mabbott DJ, et al. Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis. World J Pediatr. 2023;19:727\u201340.","journal-title":"World J Pediatr"},{"key":"4321_CR55","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s12094-024-03624-z","volume":"27","author":"EM Corrales-Garc\u00eda","year":"2025","unstructured":"Corrales-Garc\u00eda EM, Aristu-Mendioroz JJ, Castro-Novais J, Matute-Mart\u00edn R, Learra-Mart\u00ednez MC, Delgado-L\u00f3pez PD. Current state of proton therapy for tumors of the central nervous system in Spain: physical bases, indications, controversies and perspectives. Clin Transl Oncol. 2025;27:858\u201370. https:\/\/doi.org\/10.1007\/s12094-024-03624-z.","journal-title":"Clin Transl Oncol"},{"key":"4321_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.clon.2023.07.010","volume":"35","author":"S Gaito","year":"2023","unstructured":"Gaito S, Burnet NG, Aznar MC, Marvaso G, Jereczek-Fossa BA, Crellin A, et al. Proton beam therapy in the reirradiation setting of brain and base of skull tumour recurrences. Clin Oncol (R Coll Radiol). 2023;35:673\u201381.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4321_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.radonc.2019.04.027","volume":"137","author":"S Tabrizi","year":"2019","unstructured":"Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, et al. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol. 2019;137:95\u2013101.","journal-title":"Radiother Oncol"},{"key":"4321_CR58","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.22.01148","volume":"40","author":"JT Yang","year":"2022","unstructured":"Yang JT, Wijetunga NA, Pentsova E, Wolden S, Young RJ, Correa D, et al. Randomized phase ii trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis. J Clin Oncol Off J Am Soc Clin Oncol. 2022;40:3858\u201367.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4321_CR59","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/COC.0b013e318280d614","volume":"37","author":"N Xu","year":"2014","unstructured":"Xu N, Ho MW, Li Z, Morris CG, Mendenhall NP. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease? Am J Clin Oncol. 2014;37:568\u201374.","journal-title":"Am J Clin Oncol"},{"key":"4321_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-022-06516-4","volume":"192","author":"D Alterio","year":"2022","unstructured":"Alterio D, La Rocca E, Volpe S, Camarda AM, Casbarra A, Russell-Edu W, et al. Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature. Breast Cancer Res Treat. 2022;192:249\u201363.","journal-title":"Breast Cancer Res Treat"},{"key":"4321_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0140-6736(25)01962-2","volume":"407","author":"SJ Frank","year":"2026","unstructured":"Frank SJ, Busse PM, Lee JJ, Rosenthal DI, Hernandez M, Swanson DM, et al. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet (London, England). 2026;407:174\u201384.","journal-title":"Lancet (London, England)"},{"key":"4321_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.32440\/ar.2023.140.03.rev01","volume":"140","author":"F Calvo","year":"2023","unstructured":"Calvo F, G\u00f3mez Caama\u00f1o A, Albiach C, Rodr\u00edguez MC, Moreno AJ, Sagredo J, et al. Proton therapy and cancer: clinical horizon 2030 in Spain. An RANM. 2023;140:233\u201351.","journal-title":"An RANM"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04321-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:01:55Z","timestamp":1780362115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04321-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":62,"alternative-id":["4321"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04321-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}